4.6 (80) · € 9.50 · En stock
Frontiers Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials
Abstract WMP4: Intravenous Thrombolysis Before Endovascular Treatment Leads to Higher Hospital Charges Without Improving Outcomes
Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori infection: a multicenter, randomized controlled clinical trial - Hao Mei, Yan Guo, Jing-Tao Zhao, Jun
Escherichia coli resistance, treatment patterns and clinical outcomes among females with uUTI in Germany: a retrospective physician-based chart review study
Overweight and obesity are not associated with worse clinical outcomes in COVID-19 patients treated with fixed-dose 6 mg dexamethasone
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease
Hospitalization Among Patients Treated With Molnupiravir: A Retrospective Study of Administrative Data - ScienceDirect
Burden and Impact of Toxicities on Outcomes for Aggressive B Cell Non-Hodgkin Lymphoma Patients after CD19-Directed Chimeric Antigen Receptor T Cell: Real-World Experience - Biology of Blood and Marrow Transplantation
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial - The Lancet
Changes in Quality of Care after Hospital Mergers and Acquisitions
Long-term Safety and Effectiveness of Abatacept Treatment in Patients with JIA: 5-year Results from the PRCSG/PRINTO JIA Real-World Registry - ACR Meeting Abstracts
Frontiers Prognostic Significance of B-Type Natriuretic Peptide in Patients With Left Ventricular Thrombus
The Effects of Theophylline on Hospital Admissions and Exacerbations in COPD Patients (25.04.2014)